RemeGen Co (FRA:REG) Other Gross PPE: €0.0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:REG RemeGen Co Ltd FRA:REG
47 GF Score
Price €8.44
GF Value €23.82
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is RemeGen Co Other Gross PPE?

RemeGen Co FRA:REG +0.71% 47 Other Gross PPE is €0.0 Mil as of Jun. 2026. GuruFocus rates FRA:REG with a GF Score™ of 47/100 and a GF Value™ of €23.82 (Possible Value Trap). The stock has 5 warning signs investors should review.

RemeGen Co's Other Gross PPE for the quarter that ended in Jun. 2026 was €0.0 Mil.

RemeGen Co's quarterly Other Gross PPE increased from Jun. 2025 (€0.0 Mil) to Dec. 2025 (€415.2 Mil) but then declined from Dec. 2025 (€415.2 Mil) to Jun. 2026 (€0.0 Mil).

RemeGen Co's annual Other Gross PPE declined from Dec. 2023 (€44.1 Mil) to Dec. 2024 (€0.0 Mil) but then increased from Dec. 2024 (€0.0 Mil) to Dec. 2025 (€22.1 Mil).

RemeGen Co Other Gross PPE Historical Data

* Premium members only.

The historical data trend for RemeGen Co's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RemeGen Co Other Gross PPE Chart

RemeGen Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Gross PPE
Get a 7-Day Free Trial 27.73 36.50 44.13 0.00 22.13

RemeGen Co Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 415.24 0.00
FRA:REG
47GF Score
RemeGen Co Ltd FRA:REG
Other Gross PPE is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

RemeGen Co Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

Frequently Asked Questions Learn more about Other Gross PPE →
What does a Other Gross PPE of €0.0 Mil mean?
RemeGen Co (FRA:REG) has a Other Gross PPE of €0.0 Mil as of Jun. 2026. Other Gross PPE is property, plant and equipment recorded on a company's balance sheet that not otherwise classified. View historical data on RemeGen Co and its competitors.
Is RemeGen Co's Other Gross PPE too high?
RemeGen Co's current Other Gross PPE is €0.0 Mil. Overall, RemeGen Co has a GF Score™ of 47/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does RemeGen Co's Other Gross PPE compare to VRTX and REGN?
RemeGen Co's Other Gross PPE of €0.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Gross PPE for a Biotechnology company?
A good Other Gross PPE depends on the Biotechnology industry context. However, Other Gross PPE should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Gross PPE mean?
A high Other Gross PPE can signal that a stock is expensive relative to its fundamentals. Other Gross PPE is property, plant and equipment recorded on a company's balance sheet that not otherwise classified. View historical data on RemeGen Co and its competitors. RemeGen Co's current Other Gross PPE is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RemeGen Co stock overvalued right now?
Based on GuruFocus' analysis, RemeGen Co (FRA:REG) is currently considered Possible Value Trap. The stock's GF Value™ is €23.82, compared to a current price of €8.44 — trading 64.6% below its estimated fair value. The current Other Gross PPE is €0.0 Mil. RemeGen Co's overall GF Score™ is 47/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Gross PPE calculated?
Other Gross PPE is calculated from a company's financial statements. For RemeGen Co (FRA:REG), the current Other Gross PPE is €0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is RemeGen Co (FRA:REG) Overvalued in 2026?

Based on GuruFocus' analysis, RemeGen Co stock appears to be undervalued. The current stock price of €8.44 is trading 64.6% below its estimated GF Value™ of €23.82. GuruFocus considers RemeGen Co to be Possible Value Trap.

Key valuation signals for FRA:REG:

  • Other Gross PPE: €0.0 Mil
  • GF Value™: €23.82 vs. price of €8.44 (64.6% below fair value)
  • GF Score™: 47/100 with 5 warning signs

No single metric tells the full story. See the FRA:REG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

RemeGen Co Business Description

Address 58 Middle Beijing Road, Yantai Area of Shandong Pilot Free Trade Zone, Yantai Development Zone, Yantai, CHN
RemeGen Co Ltd is a China-based company mainly engaged in the research, development and manufacture of biopharmaceuticals. The company offers Telitacicept (RC18) for use in the treatment of systemic lupus erythematosus an autoimmune disease and Disitamab Vedotin (RC48) for use in the treatment of various cancers. The company's products are mainly used to treat severe diseases such as autoimmune diseases, oncology, and ophthalmology. It has its operations in China and the USA and derives the majority of its revenue from China.
47GF Score

Get the complete analysis for FRA:REG

Other Gross PPE is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€8.44
Price
€23.82
GF Value